Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

John H. Halpern, M.D.

TitleAssistant Professor of Psychiatry
InstitutionMcLean Hospital
DepartmentPsychiatry
AddressMclean Hospital
Laboratory for Integrative Psychiatry, OAKS BLDG
115 Mill St
Belmont MA 02478
Phone617/855-3703
Fax617/855-3859

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Halpern JH. Reply to: 'Illicit drugs and cluster headache: An inevitable discussion'. Cephalalgia. 2013 May; 33(7):496-7.
    View in: PubMed
  2. Passie T, Emrich HM, Karst M, Brandt SD, Halpern JH. Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence. Drug Test Anal. 2012 Jul-Aug; 4(7-8):649-59.
    View in: PubMed
  3. Halpern JH. The right medicine for World Drug Day. Indian J Med Res. 2012 Jun; 135(6):801-2.
    View in: PubMed
  4. Sinke C, Halpern JH, Zedler M, Neufeld J, Emrich HM, Passie T. Genuine and drug-induced synesthesia: a comparison. Conscious Cogn. 2012 Sep; 21(3):1419-34.
    View in: PubMed
  5. Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction. 2011 Apr; 106(4):777-86.
    View in: PubMed
  6. Karst M, Halpern JH, Bernateck M, Passie T. The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series. Cephalalgia. 2010 Sep; 30(9):1140-4.
    View in: PubMed
  7. Krebs TS, Johansen PØ, Jerome L, Halpern JH. Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users. Psychol Med. 2009 May; 39(5):876-8.
    View in: PubMed
  8. Halpern AL, Halpern JH, Doherty SB. "Enhanced" interrogation of detainees: do psychologists and psychiatrists participate? Philos Ethics Humanit Med. 2008; 3:21.
    View in: PubMed
  9. Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Med Sci Monit. 2008 Aug; 14(8):SR15-22.
    View in: PubMed
  10. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008 Jun; 103(6):1048-50.
    View in: PubMed
  11. Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A. The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther. 2008; 14(4):295-314.
    View in: PubMed
  12. Sewell RA, Halpern JH, Pope HG. Response of cluster headache to psilocybin and LSD. Neurology. 2006 Jun 27; 66(12):1920-2.
    View in: PubMed
  13. Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG. Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry. 2005 Oct 15; 58(8):624-31.
    View in: PubMed
  14. Halpern JH, Sewell RA. Hallucinogenic botanicals of America: a growing need for focused drug education and research. Life Sci. 2005 Dec 22; 78(5):519-26.
    View in: PubMed
  15. Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004 Aug 16; 75(2):135-47.
    View in: PubMed
  16. Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004 May; 102(2):131-8.
    View in: PubMed
  17. Halpern AL, Halpern JH, Freedman AM. Now is the time for AAPL to demonstrate leadership by advocating positions of social importance. J Am Acad Psychiatry Law. 2004; 32(2):180-3.
    View in: PubMed
  18. Halpern JH. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs: pilot data from “pure” users versus controls. Int J Neuropsychopharmacol. 2004; 7(Suppl 1):S85.
  19. Halpern JH. Hallucinogens: an update. Curr Psychiatry Rep. 2003 Oct; 5(5):347-54.
    View in: PubMed
  20. Duckworth K, Halpern JH, Schutt RK, Gillespie C. Use of schizophrenia as a metaphor in US newspapers. Psychiatr Serv. 2003 Oct; 54(10):1402-4.
    View in: PubMed
  21. Halpern JH, Sholar MB, Glowacki J, Mello NK, Mendelson JH, Siegel AJ. Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration. J Clin Endocrinol Metab. 2003 Mar; 88(3):1188-93.
    View in: PubMed
  22. Halpern JH, Pope HG. Hallucinogen persisting perception disorder: what do we know after 50 years? Drug Alcohol Depend. 2003 Mar 1; 69(2):109-19.
    View in: PubMed
  23. El-Mallakh RS, Halpern JH, Abraham HD. Hallucinogen and MDMA related disorders. Psychiatry (Tasman A, Lieberman J, Kay J, editors). 2003; 1046-65.
  24. Halpern JH, Pope HG Jr, Sherwood A, Hudson JI, Yurgelun-Todd D. Neuropsychological effects of long-term hallucinogen use versus alcoholism in Native Americans: cultural limitations of tests. Drug Alcohol Depend. 2002; 66(Suppl 1):S73-4.
  25. Mendelson JH, Mello NK, Sholar MB, Siegel AJ, Mutschler N, Halpern J. Temporal concordance of cocaine effects on mood states and neuroendocrine hormones. Psychoneuroendocrinology. 2002 Jan-Feb; 27(1-2):71-82.
    View in: PubMed
  26. Halpern JH, Pope HG. Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry. 2001 Mar; 158(3):481-3.
    View in: PubMed
  27. Halpern JH, Pope HG Jr, Sherwood A, Hudson JI, Yurgelun-Todd D. Neuropsychological effects of long-term hallucinogen use in Native Americans. Drug Alcohol Depend. 2001; 63(Suppl 1):S62.
  28. Piro L, Garmire G, Garcia M, Stratta G, Costa E, Feroci M, Mészáros P, Vietri M, Bradt H, Frail D, Frontera F, Halpern J, Heise J, Hurley K, Kawai N, Kippen RM, Marshall F, Murakami T, Sokolov VV, Takeshima T, Yoshida A. Observation of X-ray lines from a gamma-ray burst (GRB991216): evidence of moving ejecta from the progenitor. Science. 2000 Nov 3; 290(5493):955-8.
    View in: PubMed
  29. Halpern JH. Hallucinogens, anesthetic agents, and amphetamines. Pharmaceutical News. 2000; 7(5):21-9.
  30. Halpern JH. Treatment of attention-deficit/hyperactivity disorder. JAMA. 1999 Apr 28; 281(16):1491.
    View in: PubMed
  31. Halpern JH, Pope HG. Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend. 1999 Feb 1; 53(3):247-56.
    View in: PubMed
  32. Sholar MB, Mendelson JH, Mello NK, Siegel AJ, Halpern JH. ACTH, DHEA, and cortisol increases after 0.2 mg/kg cocaine i.v. administration. NIDA Research Monograph. 1999; 180:207.
  33. Halpern JH, Halpern AL. The violence-prone offender in the crminal justice system: prospects for prevention and treatment in the 21st Century. Proceedings of the World Congress on Violence, 1998. 1998; 84.
  34. Halpern JH, Mendelson JH, Glowacki J, Sholar MB, Lesieur-Brooks A, Siegel AJ, Pesok AL. Diminished cytokine IL-6 response in men and women after i.v. cocaine administration. NIDA Research Monograph. 1998; 179:46.
  35. Sholar MB, Mendelson JH, Mello NK, Siegel AJ, Halpern JH. Gender differences in ACTH and cortisol responses to i.v. cocaine administration. NIDA Research Monograph. 1998; 179:150.
  36. Mendelson JH, Sholar MB, Mello NK, Siegel AJ, Halpern JH. Cocaine pharmacokinetics in men and in women during two phases of the menstrual cycle. NIDA Research Monograph. 1998; 179:149.
  37. Halpern JH, Halpern AL. Addiction treatment in the 21st Century: new therapeutic approaches and their forensic implications. Proceedings of the American Academy of Forensic Sciences. 1997; III:179-80.
  38. Halpern JH. The use of hallucinogens in the treatment of addiction. Addiction Research. 1996; 4(2):177-189.
  39. Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V, et al. Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States. Vaccine. 1995 Dec; 13(17):1631-5.
    View in: PubMed
  40. Halpern JH. Involvement of physicians in capital punishment (Letter). New York State Journal of Medicine. 1991; 91(6):271-72.
  41. MacKay A, Halpern J, McLoughlin E, Locke J, Crawford JD. A comparison of age-specific burn injury rates in five Massachusetts communities. Am J Public Health. 1979 Nov; 69(11):1146-50.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Halpern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_